{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:27:46Z","timestamp":1790803666109,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10875-019-00690-9","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T20:02:46Z","timestamp":1573243366000},"page":"114-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib"],"prefix":"10.1007","volume":"40","author":[{"given":"Xiaolei","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunju","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5210-2971","authenticated-orcid":false,"given":"Shunying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,8]]},"reference":[{"issue":"6","key":"690_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","volume":"371","author":"Y Liu","year":"2014","unstructured":"Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Montealegre Sanchez GA, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014;371(6):507\u201318.","journal-title":"N Engl J Med"},{"issue":"12","key":"690_CR2","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.autrev.2015.08.002","volume":"14","author":"C Picard","year":"2015","unstructured":"Picard C, Mathieu A-L, Hasan U, Henry T, Jamilloux Y, Walzer T, et al. Inherited anomalies of innate immune receptors in pediatric-onset inflammatory diseases. Autoimmun Rev. 2015;14(12):1147\u201353.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"690_CR3","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.1172\/JCI79100","volume":"124","author":"N Jeremiah","year":"2014","unstructured":"Jeremiah N, Neven B, Gentili M, Callebaut I, Maschalidi S, Stolzenberg MC, et al. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest. 2014;124(12):5516\u201320.","journal-title":"J Clin Invest"},{"issue":"3","key":"690_CR4","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.chest.2016.02.682","volume":"150","author":"C Picard","year":"2016","unstructured":"Picard C, Thouvenin G, Kannengiesser C, Dubus JC, Jeremiah N, Rieux-Laucat F, et al. Severe pulmonary fibrosis as the first manifestation of interferonopathy (TMEM173 mutation). Chest. 2016;150(3):e65\u201371.","journal-title":"Chest."},{"issue":"3","key":"690_CR5","first-page":"179","volume":"56","author":"Z Yu","year":"2018","unstructured":"Yu Z, Zhong L, Song H, et al. Stimulator of interferon genes-associated vasculopathy with onset in infancy: first case report in China. Chin J Pediatr. 2018;56(3):179\u201385.","journal-title":"Chin J Pediatr"},{"key":"690_CR6","first-page":"1","volume":"22","author":"W Shoman","year":"2019","unstructured":"Shoman W, El Chazli Y, ElSawy I, et al. First Egyptian patient with STING-associated vasculopathy with onset in infancy. Scand J Rheumatol. 2019;22:1\u20132.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"690_CR7","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/art.38998","volume":"67","author":"E Omoyinmi","year":"2015","unstructured":"Omoyinmi E, Melo Gomes S, Nanthapisal S, Woo P, Standing A, Eleftheriou D, et al. Stimulator of interferon genes-associated vasculitis of infancy. Arthritis Rheum. 2015;67(3):808.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"690_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jaci.2016.10.031","volume":"140","author":"I Melki","year":"2017","unstructured":"Melki I, Rose Y, Uggenti C, van Eyck L, Fr\u00e9mond ML, Kitabayashi N, et al. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling. J Allergy Clin Immunol. 2017;140(2):543\u201352.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"690_CR9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jamadermatol.2015.0251","volume":"151","author":"J Munoz","year":"2015","unstructured":"Munoz J, Rodi\u00e8re M, Jeremiah N, Rieux-Laucat F, Oojageer A, Rice GI, et al. Stimulator of interferon genes\u2013associated vasculopathy with onset in infancy a mimic of childhood granulomatosis with polyangiitis. JAMA Dermatol. 2015;151(8):872\u20137.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"690_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jaad.2015.10.007","volume":"74","author":"J Chia","year":"2016","unstructured":"Chia J, Eroglu FK, \u00d6zen S, Orhan D, Montealegre-Sanchez G, de Jesus AA, et al. Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy. J Am Acad Dermatol. 2016 Jan;74(1):186\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"690_CR11","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1172\/JCI98814","volume":"128","author":"GAM Sanchez","year":"2018","unstructured":"Sanchez GAM, Reinhardt A, Ramsey S. JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest. 2018;128(7):3041\u201352.","journal-title":"J Clin Invest"},{"issue":"5","key":"690_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1164\/rccm.201510-2102LE","volume":"194","author":"SL Clarke","year":"2016","unstructured":"Clarke SL, Pellowe EJ, de Jesus AA, et al. Interstitial lung disease caused by STING-associated vasculopathy with onset in infancy. Am J Respir Crit Care Med. 2016 Sep 1;194(5):639\u201342.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"690_CR13","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jaci.2016.10.030","volume":"139","author":"J Seo","year":"2017","unstructured":"Seo J, Kang JA, Suh DI, Park EB, Lee CR, Choi SA, et al. Tofacitinib relieves symptoms of stimulator of interferon genes (STING)\u2013associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173. J Allergy Clin Immunol. 2017;139(4):1396\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"690_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1136\/annrheumdis-2016-209841","volume":"76","author":"N K\u00f6nig","year":"2017","unstructured":"K\u00f6nig N, Fiehn C, Wolf C, Schuster M, Cura Costa E, T\u00fcngler V, et al. Familial chilblain lupus due to a gain-of-function mutation in STING. Ann Rheum Dis. 2017 Feb;76(2):468\u201372.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"690_CR15","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1093\/rheumatology\/kex316","volume":"56","author":"MN Manoussakis","year":"2017","unstructured":"Manoussakis MN, Mavragani CP, Nezos A, Zampeli E, Germenis A, Moutsopoulos HM. Type I interferonopathy in a young adult. Rheumatology (Oxford). 2017;56(12):2241\u20133.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"690_CR16","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.celrep.2018.03.115","volume":"23","author":"H Konno","year":"2018","unstructured":"Konno H, Chinn IK, Hong D, Orange JS, Lupski JR, Mendoza A, et al. Pro-inflammation associated with a gain-of-function mutation (R284S) in the innate immune sensor STING. Cell Rep. 2018;23(4):1112\u201323.","journal-title":"Cell Rep"},{"key":"690_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01535","volume":"9","author":"RG Saldanha","year":"2018","unstructured":"Saldanha RG, Balka KR, Davidson S, Wainstein BK, Wong M, Macintosh R, et al. A mutation outside the dimerization domain causing atypical STING- associated vasculopathy with onset in infancy. Front Immunol. 2018;9:1535.","journal-title":"Front Immunol"},{"issue":"1","key":"690_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12969-016-0094-4","volume":"14","author":"S Volpi","year":"2016","unstructured":"Volpi S, Picco P, Caorsi R, Candotti F, Gattorno M. Type I interferonopathies in pediatric rheumatology. Pediatr Rheumatol Online J. 2016;14(1):35.","journal-title":"Pediatr Rheumatol Online J"},{"key":"690_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2017.10.001","volume":"187","author":"S Volpi","year":"2018","unstructured":"Volpi S, Tsui J, Mariani M, Pastorino C, Caorsi R, Sacco O, et al. Type I interferon pathway activation in COPA syndrome. Clin Immunol. 2018;187:33\u20136.","journal-title":"Clin Immunol"},{"issue":"73","key":"690_CR20","doi-asserted-by":"publisher","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","volume":"3","author":"GS Garcia-Romo","year":"2011","unstructured":"Garcia-Romo GS, Caielli S, Vega B, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med. 2011;3(73):73ra20.","journal-title":"Sci Transl Med"},{"issue":"6","key":"690_CR21","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.jaci.2016.07.015","volume":"138","author":"ML Fr\u00e9mond","year":"2016","unstructured":"Fr\u00e9mond ML, Rodero MP, Jeremiah N, Belot A, Jeziorski E, Duffy D, et al. Efficacy of the Janus kinase 1\/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children. J Allergy Clin Immunol. 2016 Dec;138(6):1752\u20135.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"690_CR22","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1136\/annrheumdis-2016-210504","volume":"75","author":"MP Rodero","year":"2016","unstructured":"Rodero MP, Fr\u00e9mond ML, Rice GI, Neven B, Crow YJ. JAK inhibition in STING-associated interferonopathy. Ann Rheum Dis. 2016;75(12):e75.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"690_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s10875-019-00645-0","volume":"39","author":"S Volpi","year":"2019","unstructured":"Volpi S, Insalaco A, Caorsi R, Santori E, Messia V, Sacco O, et al. Efficacy and adverse events during Janus kinase inhibitor treatment of SAVI syndrome. J Clin Immunol. 2019;39(5):476\u201385.","journal-title":"J Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-019-00690-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:01:44Z","timestamp":1659056504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-019-00690-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,8]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["690"],"URL":"https:\/\/doi.org\/10.1007\/s10875-019-00690-9","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,8]]},"assertion":[{"value":"1 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}